A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

Trial ID or NCT#

NCT05201781

Status

not recruiting iconNOT RECRUITING

Purpose

The purpose of this study is to collect long-term follow-up data on delayed adverse events after administration of ciltacabtagene autoleucel (cilta-cel), and to characterize and understand the long-term safety profile of cilta-cel.

Official Title

Long-term Follow-up Study for Participants Previously Treated With Ciltacabtagene Autoleucel

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Show Less

Investigator(s)

Surbhi Sidana, MD
Surbhi Sidana, MD
Blood and marrow transplant specialist, Hematologist-Oncologist
Assistant Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)

Contact us to find out if this trial is right for you.

Contact

Kelly Chyan
650-625-8130

View on ClinicalTrials.gov